Definitive Contract W81XWH20C0074

Award Date 9/24/20
Potential Completion Date 1/23/23
Potential Value $1M
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hattiesburg, MS 39401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This is a U.S. Department of Defense contract awarded to Hybrid Plastics, Incorporated, a for-profit manufacturer, for the SBIR Phase III development of a POSS viscoelastic hemostat under Contract Number W911NF21C0038. The contract has a ceiling value of $8,000,000.00 and is a cost-plus-fixed-fee definitive contract with a completion date of September 24, 2025. The contract was awarded on April 7, 2021 by the Research, Development and Engineering Command (RDECOM), which is part of the U.S. Army....
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
The Department of the Army Medical Command awarded a $148,203.61 Small Business Innovation Research (SBIR) Phase I contract to Haima Therapeutics LLC, a woman-owned small business, for research and development of a nanotechnology-enabled biosynthetic whole-blood surrogate for hemostatic resuscitation. This contract supports the Congressionally Directed Medical Research Programs' Combat Readiness-Medical Research Program under a Rapid Development and Translational Research Award. Additionally,...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Nanosonic Inc., a private company specializing in advanced materials and devices. The $1,000,000.00 contract is for the development of a "Multipurpose Spall Protective, Energy Absorbing Hybridsil Material for Military Vehicle Interiors", which is a research and development effort under the SBIR program. The contract has been...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Chromologic LLC, a minority-owned small business, to design, develop, and construct a breadboard prototype for an on-demand process to generate 10-15% concentrations of aqueous hydrogen peroxide. The $167,466.50 contract has a firm fixed price and a completion date of October 27, 2021. Chromologic, a manufacturer of goods, has...
This is a firm-fixed-price SBIR Phase I contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Plasmability LLC, a small business located in Austin, Texas. The contract, valued at $148,900.44, is part of the Small Business Innovation Research (SBIR) program and has a period of performance through March 27, 2019. As a SBIR Phase I award, this contract represents the initial research and development effort to explore the feasibility of a new technology or...
This is a Firm Fixed Price contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Materials Sciences LLC, a small business, for $149,982.42. The contract is for the Small Business Innovation Research (SBIR) Phase I effort entitled "Hybrid Thermoplastic Matrix Fabrication Methods for Missile Support." As an SBIR Phase I award, this contract provides early-stage research funding to develop new composite materials and fabrication methods for...
<p>This is a $150,000.00 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Resusitech Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for a DHP SBIR PHASE I PROPOSAL H161-009-0159 and has a period of performance through April 14, 2017. This SBIR Phase I award was set aside for small businesses.</p>
This Phase I Small Business Innovation Research (SBIR) Program award from the Department of the Army has a potential value of $249,070.50. The prime contractor is Superior Sustainable Solutions LLC, a for-profit, Asian-Pacific American owned small business. The completion date for this firm fixed price contract is May 28, 2023. The place of performance is Houghton, Michigan. This total small business set-aside award supports the Army's SBIR Program, which provides early-stage research and...

Hybrid Plastics, Incorporated has been awarded a definitive contract valued at one million U.S. dollars by the Department of the Army Medical Command to support Phase II of the Small Business Innovation Research program. Under this firm fixed price contract, Hybrid Plastics will conduct medical research and development efforts over a thirty-month period ending in January 2023 to further the goals of the Army's Hemostatic Agent Development initiative. The place of performance will be in Hattiesburg, Mississippi. This total small business set-aside award provides continued support for Hybrid Plastics' efforts to advance hemorrhage control technologies under the Department of Defense's SBIR program, which aims to fund research and development at small businesses that could meet Army needs.

Generated 12/25/23, 5:22 AM